Continue Reading
Full article on Unknown
Cathie Wood shells out $1.3 million on biotech stock
Market Intelligence Analysis
AI-Powered
Why This Matters
Cathie Wood, a prominent investor, has invested $1.3 million in Intellia Therapeutics, a biotech company, by purchasing 145,153 shares. This move comes despite the company's forgettable year, with its stock closing in the negative. The investment may indicate a positive outlook for the company's future prospects.
Market Impact
Market impact analysis based on bullish sentiment with 80% confidence.
Sentiment
Bullish
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in the gene-editing play. For the most part, it has been a forgettable year for Intellia stock, closing out another year in the negative. The ...
Original article published by
Unknown
on December 31, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.